Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 977-982, February 15, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bolscher, J. G. M.
Right arrow Articles by Smets, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bolscher, J. G. M.
Right arrow Articles by Smets, L. A.

Modification of Cell Surface Carbohydrates and Invasive Behavior by an Alkyl Lysophospholipid1

Jan G. M. Bolscher2, Denis C. C. Schallier3, Henny van Rooy, Guy A. Storme and Lou A. Smets

Division of Cell Biology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Huis, 121 Plesmanlaan, 1066 CX Amsterdam, The Netherlands [J. G. M. B., D. C. C. S., H. v. R., L. A. S.] and Oncologic Centre, Department of Radiotherapy, Academic Hospital Free University, Brussels, Laarbeeklaan 101, 1090 Brussels, Belgium [G. A. S.]

The effect of the alkyl lysophospholipid racemic-1-O-octadecyl-2-O-methyl glycero-3-phosphocholine on the expression of cell surface carbohydrates of four matched pairs of normal and malignant cells was studied using chromatographic techniques. After treatment with alkyl lysophospholipid, glycopeptides proteolytically derived from normal and malignant cells displayed a shift in the size distribution profiles obtained by gel filtration. These drug-induced changes in molecular weight distribution were expressed most strongly in untransformed cells and resembled the carbohydrate alterations found after their malignant transformation. Desialylation abolished the effect of alkyl lysophospholipid, thus suggesting an increased amount of sialic acid in the surface carbohydrates of drug-treated cells.

Chromatography of glycopeptides on concanavalin A-Sepharose, Ricinus communis agglutinin I-agarose, and Bio-Gel P-4 columns excluded a higher degree of branching but suggested addition of extra terminal sialic acid residues as the major cause of the observed alterations. Alkyl lysophospholipid stimulated glycoprotein sialylation of normal cells to the level observed in malignant cells, thus inducing a "malignant-like" surface phenotype. The drug-induced carbohydrate changes in normal chick heart tissue prevented its being invaded by tumor cells when tested in an organotypic assay. The alkyl lysophospholipid thus appears to modulate in a nontoxic fashion the expression of surface molecules implicated in various cellular interactions including invasiveness.

1 Supported by grants from the Netherlands Cancer Foundation, Koningin Wilhelmina Fonds (NKI-KWF 84-16), Amsterdam, the Netherlands, and from NAVO and Belgisch Werk tegen Kanker, Brussels, Belgium.

2 To whom requests for reprints should be addressed.

3 Present address: Bristol-Meyers Belgium, 185–187 Terhulpsesteenweg, 1170 Brussels, Belgium.

Received 10/20/86. Revised 10/13/87. Accepted 11/18/87.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.